title: Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.
abstract: OBJECTIVE
  To compare trovafloxacin, a new quinolone antibiotic with enhanced activity against Neisseria gonorrhoeae, with ofloxacin as single-dose oral therapy for uncomplicated gonococcal urethritis or cervicitis.
  
  
  METHODS
  In this multicenter, double-blind trial, 625 patients (270 men, 355 women) with uncomplicated gonococcal urethritis or cervicitis received one 100-mg tablet of trovafloxacin or two 200-mg capsules of ofloxacin as a single dose under direct supervision.
  
  
  RESULTS
  Single-dose oral therapy with trovafloxacin was equivalent both bacteriologically and clinically to ofloxacin. Among evaluable patients, N gonorrhoeae was eradicated in 99% of trovafloxacin recipients and in 98% of ofloxacin recipients. Each treatment was well tolerated; vaginitis was the most frequently observed side effect (4% trovafloxacin, 7% ofloxacin).
  
  
  CONCLUSIONS
  Based on the results presented here, trovafloxacin is a promising agent for single-dose therapy of uncomplicated gonorrhea.
authors.affiliation: Department of Medicine, Indiana University School of Medicine, Indianapolis 46202-5124, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Jones
authors.forename: J
authors.initials: J
authors.lastname: Schwebke
authors.forename: E M
authors.initials: EM
authors.lastname: Thorpe
authors.forename: Z A
authors.initials: ZA
authors.lastname: Dalu
authors.forename: P
authors.initials: P
authors.lastname: Leone
authors.forename: R B
authors.initials: RB
authors.lastname: Johnson
mesh_terms: D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D024841:Fluoroquinolones; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009287:Naphthyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014526:Urethritis / Q000188:drug therapy*; D002575:Uterine Cervicitis / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C080163:trovafloxacin; D015242:Ofloxacin